Table 1 Summary of modeled innovations
Innovation class | Innovations | Health condition(s) | Treatment continuum | Platform | Target SDG population |
|---|---|---|---|---|---|
New formulations of oxytocin | 1) Inhaled oxytocin 2) Sublingual oxytocin | Postpartum hemorrhage (atony) | Prevention and treatment | Drug | Mothers |
Uterine balloon tamponade (UBT) | Every Second Matters UBT (ESM-UBT) | Postpartum hemorrhage (atony) | Treatment | Device | Mothers |
Simple, safe device for assisted delivery | Odon devicea | Prolonged and obstructed labor | Treatment | Device | Mothers and neonates |
Chlorhexidine for umbilical cord care | 1) Chlorhexidine liquid 2) Chlorhexidine gel | Sepsis | Prevention | Drug | Neonates |
New treatments for severe diarrhea | 1) DiaResQ 2) Qwell | Diarrhea | Treatment | Therapeutics | Children under 5 |
New tools for small-scale water treatment | Zimba automated batch chlorinator | Diarrhea | Prevention | Device | Children under 5 |
Portable pulse oximeters to measure oxygen | Non-contact mobile oximeter | Pneumonia | Diagnosis | Device | Children under 5 |
Better respiratory rate monitors | INSPIRE respiratory rate monitor | Pneumonia | Diagnosis | Device | Children under 5 |